Pharmacokinetics: Drug Distribution and Drug Reservoirs

Slides:



Advertisements
Similar presentations
HLTH 340 Lecture A4 Toxicokinetic processes: Distribution (part-1)
Advertisements

Administration and Absorption of Drugs. Factors that effect the action of a drug 1.Rate of accumulation at its site of action 2.Concentration of the drug.
Distribution & Fate Lesson 5. Distribution n Drug disperses throughout system l does not reach target l silent receptors n Distributes in l Blood & extracellular.
Nomenclature: Every drug has three names: 1) Chemical Name:  The drug is named according to its chemical structure. 2) Generic name (common name): 
VM 8314 Dr. Wilcke Drug Distribution. VM 8314 Dr. Wilcke  Vascular space =  Plasma/plasma water + (extracellular space)  Many RBC’s (intracellular.
DISTRIBUTION The body is a container in which a drug is distributed by blood (different flow to different organs) - but the body is not homogeneous. Factors.
Pharmacotherapy in the Elderly Paola S. Timiras May, 2007.
Pharmacotherapy in the Elderly Judy Wong
Pharmacokinetics Chapter 4.
SEMINAR ON VOLUME OF DISTRIBUTION BY SUMAN.THOTA M.PHARM 1 ST YEAR (1 ST SEM) INDUSTRIAL PHARMACY U.C.P.SC.
Pharmacokinetics Based on the hypothesis that the action of a drug requires presence of a certain concentration in the fluid bathing the target tissue.
Pharmacokinetics (PK): What the body does to the drug? Most drugs: Enter the body by crossing barriers Distributed by the blood to the site of action Biotransform.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 2 Drug Action and Handling.
Pharmacology Department
ADME And PHARMACOKINETICS.
Is the passage of drug from its site of administration to its site of action through cell membranes. Sites of Administration Sites of action Cell membrane.
Prof. Hanan Hagar Pharmacology Department. What student should know  Major body fluid compartments  Concept of compartments.  Apparent volume of distribution.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 4 Pharmacokinetics.
Prof. Hanan Hagar Pharmacology Department.  Is the fraction of unchanged drug that enters systemic circulation after administration and becomes available.
PHARMACOKINETICS.
PHARMACOKINETICS CH. 4 Part 2. GETTING IN ABSORPTION Definition – the movement of a drug from the site of administration into the fluids of the body.
1 Pharmacology Pharmacokinetics –Absorption –Distribution –Biotransformation (metabolism) –Excretion Pharmacodynamics –Receptor binding –Signal transduction.
Chapter 4 Pharmacokinetics Copyright © 2011 Delmar, Cengage Learning.
Basic Pharmacokinetics The time course of drug action Collected and Prepared By S.Bohlooli, PhD.
PHARMACOKINETICS Part 3.
Core Concepts in Pharmacology Chapter 5 Pharmacokinetics.
!!!……Molecular Target Concept A gonist Antagonist.
Quantitative Pharmacokinetics
Pharmacology Department
Plasma Protein Binding
Definition: the intestinal, then hepatic degradation or alteration of an ingested medication before it enters the general circulation All blood that.
Pharmacology Department
TDM Therapeutic Drug Monitoring
DRUG ABSORPTION AND DISTRIBUTION OF DRUG
Principles of Drug Action
CHAPTER 4 L. VanValkenburg, RVT, BAS Pharmacokinetics.
By : Dr. Roshini Murugupillai
Pharmacokinetics Drug molecules interact with target sites to affect the nervous system –The drug must be absorbed into the bloodstream and then carried.
Pharmacology I Session One Pharmacological Principles.
Pharmacokienetic Principles (2): Distribution of Drugs
Basic Principles: PK By: Alaina Darby.
Drug therapy in pediatric
Chapter 3 PHARMACOKINETICS “What the body does to the drug” Lei Wang
General principles of pharmacology
Medicinal chemistry Third stage Lecture 1
Pharmaceutics 2.
Introduction to Pharmacology
Pharmacokinetics.
Pharmacokinetics: Drug Distribution and Drug Reservoirs
School of Pharmacy, University of Nizwa
Pharmacokinetics: Metabolism of Drugs
Conceptual Subdivisions of Pharmacology
Conceptual Subdivisions of Pharmacology
Pharmacokinetics: Drug Absorption
Clinical Pharmacokinetics
Pharmacokinetics: Drug Absorption
School of Pharmacy, University of Nizwa
Clinical Pharmacokinetics
Introduction to Pharmacology
Clinical Pharmacokinetics
Introduction to Pharmacology
CHAPTER 4 l. VanValkenburg, RVT, BAS
Pharmacokinetics: Drug Absorption
Pharmacokinetics: Drug Absorption
Pharmacokinetics/Pharmacodynamics
Therapeutic Drug Monitoring
Medication Administration for Pediatrics
Introduction to Pharmacology
How and Why Drugs Work PPT Series 5B
Presentation transcript:

Pharmacokinetics: Drug Distribution and Drug Reservoirs Course Coordinator Jamaluddin Shaikh, Ph.D. School of Pharmacy, University of Nizwa Lecture-7 February 25, 2012

Pharmacokinetic Components

Mechanism of Drug Distribution A process by which a drug reversibly leaves the bloodstream and enters the extracellular fluid and/or the cells of the tissues Mechanism of Drug Distribution First phase of distribution: Compose of cardiac output and regional blood flow Involvement of heart, liver, kidney, brain Steady state achieve after first few minutes of absorption Second phase of distribution: Delivery of drug to muscle, skin and fat Steady state achieve after several minutes to hours of absorption

Factors Influencing Drug Distribution Blood flow Capillary permeability Binding of the drug to plasma and tissue proteins Relative hydrophobicity of the drug Blood Flow The rate of blood flow to the tissue capillaries varies widely as a result of the unequal distribution of cardiac output to the various organs Blood flow to the brain, liver, and kidney is greater than that to the skeletal muscles; adipose tissue has a lower rate of blood flow

Capillary Permeability Capillary structure: Capillary structure varies widely in terms of the fraction drug distribution Blood-brain barrier: To enter the brain, drugs must pass through the endothelial cells of the capillaries of the CNS or be actively transported Drug structure: The chemical nature of a drug strongly influences its ability to cross cell membranes. Hydrophobic drugs readily move across most biologic membranes. By contrast, hydrophilic drugs do not readily penetrate cell membranes, and must go through the slit junctions

Brain Capillaries

Binding of Drugs to Plasma and Tissue Proteins Reversible binding to plasma proteins sequesters drugs in a nondiffusible form Plasma albumin is the major drug-binding protein and may act as a drug reservoir; i.e., as the concentration of free drug decreases due to elimination by metabolism or excretion, the bound drug dissociates from the protein. Free Drug EXCRETION TISSUE RESERVOIRS Bound Drug SYSTEMIC CIRCULATION Free Bound BIOTRANSFORMATION

Drug Reservoir Storage site of drugs in the body Drugs at storage sites are pharmacologically not active Three different storage systems: Plasma proteins Cellular reservoir Transcellular reservoir

Binding of Drugs at Plasma proteins Drug molecules may bind to plasma proteins, usually albumin Bound drugs are pharmacologically inactive; only the free, unbound drug can act on target sites in the tissues, elicit a biologic response Drug reservoir may depend on: Binding capacity of albumin Competition for binding between drugs

Binding Capacity of Albumin The binding of drugs to albumin is reversible and may show low capacity (one drug molecule per albumin molecule) or high capacity (a number of drug molecules binding to a single albumin molecule) Albumin has the strongest affinities for anionic drugs (weak acids) and hydrophobic drugs. Most hydrophilic drugs and neutral drugs do not bind to albumin

Competition for Binding Between Drugs When two drugs are given, each with high affinity for albumin, they compete for the available binding sites. These drugs may divided into two classes Class I drugs If the dose of drug is less than the binding capacity of albumin, then the dose/capacity ratio is low. The binding sites are in excess of the available drug Class II drugs These drugs are given in doses that greatly exceed the number of albumin binding sites. The dose/capacity ratio is high, and a relatively high proportion of the drug exists in the free state, not bound to albumin

Competition for Binding Between Drugs

Clinical Importance of Drug Displacement This is important when a patient taking a Class I drug, such as warfarin, is given a Class II drug, such as a sulfonamide antibiotic Warfarin is highly bound to albumin, and only a small fraction is free, i.e., most of the drug is sequestered on albumin and is pharmacologically inactive If a sulfonamide is administered, it displaces warfarin from albumin, and increases in the concentration of free warfarin in plasma

Trancellular Reservoirs Many drugs accumulate in muscle and other cells in higher concentration than in the extracellular fluid If the intracellular concentration is high and if the binding is reversible, the tissue involved may represent a suitable drug reservoir Example, during long-term administration of antimalarial agent quinacrine, the concentration of drug in liver is several thousand times that in the plasma Trancellular Reservoirs Drug also cross epithelial cells and may accumulate in the transcellular fluids Major one is synovial fluid in the joints, saliva, tears